CRON

Cronos Group Inc.

Price

$3.41

return (12m)

31.15%

p/e

17.42

p/bv

1.09

DIVIDEND YIELD

0.00%

CRON price

Cronos Group

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment CRON

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

19.65%

3 months

24.91%

1 year

31.15%

2 years

45.73%

5 years

-47.62%

10 years

880.45%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals CRON

Valuation

P/E

17.42

Sector -0.74

Industry 10.34

P/BV

1.09

Sector 1.96

Industry 2.60

P/Revenue (PSR)

6.81

Sector 1.73

Industry 1.16

EV/EBITDA

38.45

Sector -18.94

Industry 27.24

EV/EBIT

55.56

Sector -26.38

Industry -33.91

P/EBITDA

135.17

Sector -44.48

Industry -84.29

P/EBIT

-230.48

Sector -45.47

Industry 2.31

P/Total Assets

1.03

Sector 0.91

Industry 1.17

P/Net Current Assets

1.44

Sector -25.25

Industry -3.78

P/Working Capital

1.42

Sector -5.75

Industry 6.90

EPS

0.19

Sector -0.83

Industry 1.21

BVPS

2.99

Sector 3.90

Industry 15.16

Efficiency

Gross Margin

45.85%

Sector 45.46%

Industry 29.23%

EBITDA Margin

20.71%

Sector -311.16%

Industry 4.54%

EBIT Margin

14.34%

Sector -197.35%

Industry 3.11%

Operating Margin

-2.95%

Sector -22.95%

Industry 2.73%

Net Profit Margins

39.08%

Sector -28.26%

Industry 3.05%

Asset Turnover

0.04

Sector 0.13

Industry 0.28

Profitability

ROE

6.26%

Sector -30.03%

Industry 8.27%

ROA

5.93%

Sector -28.65%

Industry 3.60%

ROIC

9.57%

Sector -521.05%

Industry -2.36%

Dividends

Dividend yield

0.00%

Sector -

Industry 0.01%

Payout

0.00%

Sector -

Industry 0.78%

Debt

Current Ratio

16.18

Sector 1.85

Industry 1.48

Net Debt / EBITDA

-72.59

Sector -4.36

Industry -4.26

Net Debt / EBIT

-104.87

Sector -2.89

Industry -0.72

Net Debt / Equity

-0.71

Sector -0.42

Industry 0.04

Gross Debt / Equity

0.00

Sector -0.57

Industry 0.37

Equity/Assets

0.95

Sector 0.43

Industry 0.46

Liabilities/Assets

0.05

Sector 0.48

Industry 0.52

Growth

5Y Revenue CAGR

22.64%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

FAIR VALUE OF Cronos Group ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$3.41

Fair Value

$3.58

Upside Return potential.

4.85%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals CRON

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
CRON Cronos Group Inc.	$3.41	31.15%	0.00%	17.42	1.09	6.26%	39.08%
LLY Eli Lilly and Compay	$1,246.93	80.86%	0.51%	42.15	33.23	78.84%	33.53%
SNY Sanofi	$45.69	-7.51%	3.84%	7.49	1.38	18.43%	13.81%
GSK GlaxoSmithKline PLC	$51.78	34.76%	3.38%	16.11	4.55	28.24%	14.54%
CRMD CorMedix Inc.	$8.28	-39.52%	0.00%	3.46	1.40	40.62%	40.72%
AMPH Amphastar Pharmaceuticals Inc.	$21.52	-29.44%	0.00%	12.22	1.25	10.23%	10.76%
RDY Dr. Reddy's Laboratories Ltd.	$12.21	-15.28%	0.68%	27.65	2.50	9.03%	10.14%
ISRG Intuitive Surgical Inc.	$373.57	-21.55%	0.00%	42.99	7.38	17.15%	28.45%
NVS Novartis AG	$158.02	26.86%	2.43%	22.43	7.80	34.77%	23.92%
TMO Thermo Fisher Scientific Inc.	$628.74	26.30%	0.29%	33.21	4.38	13.19%	15.04%
ABT Abbott Laboratories	$116.67	-9.50%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$92.90	4.26%	3.08%	24.65	2.36	9.59%	13.20%
CVS CVS Health Corporation	$94.11	36.16%	2.86%	24.36	1.49	6.12%	1.18%
BSX Boston Scientific Corp.	$49.01	-53.84%	0.00%	17.71	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$93.60	-21.90%	0.00%	21.76	6.37	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$559.51	-13.33%	0.00%	38.42	27.15	70.67%	25.03%
RMD ResMed Inc.	$232.45	-19.85%	0.97%	22.21	5.20	23.41%	27.44%
DHR Danaher Corporation	$215.11	4.32%	0.66%	38.57	2.94	7.61%	15.95%
HCA HCA Healthcare Inc.	$429.24	6.69%	0.70%	13.87	-29.56	-213.15%	8.77%
COHR Coherent Inc.	$275.49	206.44%	0.00%	115.60	4.92	4.26%	7.10%
PHG Koninklijke Philips NV	$27.52	0.93%	3.68%	20.32	1.99	9.80%	6.30%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

CRON Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Cronos Group

Cronos Group Inc.

Average Investor10 user rating

4.0 (1 people)

United States

14 years

Founded: 2012

2016

Time since IPO - 10 years

665

Employees

Cronos Group Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.22 billion, with shareholders equity totaling $1.12 billion.

The company employs approximately 665 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Cronos Group Inc. reported $179.09 million in revenue, generating net income of $69.98 million.

Key financial metrics include a P/E ratio of 17.42, a price-to-book (P/B) ratio of 1.09, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CRON.

Market cap

$1.22 billion

Net worth

$1.12 billion

$1,117,440,000.00

Assets

$1.18 billion

$1,179,860,000.00

Total Shares Outstanding

374.00 million

374,000,000

Average Daily Trading Volume

$1.13 million

$1,129,548.00

Sector

Health

Industry

Pharmaceutical Products

CRON

CRON revenue and profits

Financial Results CRON

DRAG THE FRAME TO SEE MORE DATA

CRON cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CI - Cigna

$280.45 --4,17% (12M)

P/E

10.67

2.22%

ROE

16.04%

P/BV

1.71

SNY - Sanofi

$45.69 --5,26% (12M)

P/E

7.49

3.84%

ROE

18.43%

P/BV

1.38

ABT - Abbott

$116.67 --9,31% (12M)

P/E

33.60

2.33%

ROE

10.61%

P/BV

3.57

GSK - GlaxoSmithKline

$51.78 36,63% (12M)

P/E

16.11

3.38%

ROE

28.24%

P/BV

4.55

MDT - Medtronic

$92.90 5,02% (12M)

P/E

24.65

3.08%

ROE

9.59%

P/BV

2.36

TAK - Takeda Pharmaceutical

$18.24 25,91% (12M)

P/E

-55.61

3.47%

ROE

-2.20%

P/BV

1.22

FMS - Fresenius Medical Care

$23.53 --4,32% (12M)

P/E

11.52

2.61%

ROE

7.01%

P/BV

0.81

$49.01 --53,37% (12 M)

P/L

17.71

0.00%

ROE

P/VP

0.00

Frequently Asked Questions

What is the price of Cronos Group (CRON) today?

A cotação de Cronos Group (CRON) hoje está em US$ 3.41, com uma variação de 31.15% em relação ao último ano. A cotação de Cronos Group (CRON) iniciou o ano negociando na casa dos US$ 2.63 e hoje está em US$ 3.41. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Cronos Group (CRON) e dados de ações do Ibovespa e mercados internacionais.

Quando Cronos Group (CRON) paga dividendos?

Cronos Group (CRON) não distribuiu dividendos no último ano.

Is Cronos Group (CRON) a good investment?

Atualmente, Cronos Group (CRON) está cotada a US$ 3.41, com um P/L de 17.42, representando um desvio de -1,742% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 31.15 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 31.15%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Cronos Group (CRON) stock?

Investir em ações de Cronos Group (CRON) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Cronos Group (CRON) yield today?

A rentabilidade de Cronos Group (CRON) foi de 19.65% no último mês, 31.15% no último ano e -47.62% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Cronos Group (CRON) hoje, o investimento total seria de US$ 341.00, com base na cotação atual de US$ 3.41.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 447.22
Em 5 anos: US$ 178.62
Em 10 anos: US$ 3,343.33

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

CRON

Cronos Group Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment CRON

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

Graham's Fair Value

COMPARING CRON WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Cronos Group

Cronos Group Inc.

United States

14 years

2016

665

PROFIT X PRICE CRON

Financial Results CRON

CRON cash flow

Asset, Revenue and Profit Growth - CRON

CRON balance sheet

CI - Cigna

SNY - Sanofi

ABT - Abbott

GSK - GlaxoSmithKline

MDT - Medtronic

TAK - Takeda Pharmaceutical

FMS - Fresenius Medical Care

BSX - Boston Scientific

CI - Cigna

SNY - Sanofi

ABT - Abbott

GSK - GlaxoSmithKline

MDT - Medtronic

TAK - Takeda Pharmaceutical

FMS - Fresenius Medical Care

BSX - Boston Scientific

Frequently Asked Questions